Related Experiment Video
Updated: Aug 5, 2026

Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
CARDIOVASCULAR COMPLICATIONS OF CHEMOTHERAPY IN BREAST CANCER: A SCOPING REVIEW
O A Orimolade1,2, O S Ogah1,2, O A Ajagbe3,4
1Cardiology Unit, Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
Chemotherapy for breast cancer can cause heart damage, especially with anthracyclines. Early detection and preventive strategies are crucial for managing chemotherapy-induced cardiotoxicity and improving patient outcomes.
Area of Science:
- Cardio-oncology
- Pharmacology
- Oncology
Background:
- Chemotherapy, a vital breast cancer treatment, poses risks of cardiovascular toxicity.
- Anthracyclines are a key concern due to their dose-dependent cardiotoxic effects.
- Cardiotoxicity can negatively impact long-term patient outcomes.
Purpose of the Study:
- To review current evidence on chemotherapy-induced cardiotoxicity in breast cancer patients.
- To focus on anthracycline-related cardiac dysfunction, including its epidemiology, mechanisms, risk factors, detection, and prevention.
Main Methods:
- A comprehensive scoping review of peer-reviewed literature.
- Searches were conducted across major databases: PubMed, Scopus, Web of Science, and Google Scholar.
- Included studies focused on cardiovascular complications associated with chemotherapy in breast cancer.
Main Results:
- Cardiotoxicity risk correlates with cumulative anthracycline dose, combination therapy (e.g., with trastuzumab), and pre-existing cardiovascular conditions.
- Mechanisms involve oxidative stress, mitochondrial dysfunction, and topoisomerase II inhibition.
- Early detection via echocardiography and biomarkers, alongside preventive measures (dose adjustment, cardioprotective agents), shows significant benefit.
Conclusions:
- Chemotherapy-induced cardiotoxicity is a significant clinical challenge in breast cancer care.
- Implementing early detection, risk stratification, and integrated cardio-oncology care is essential.
- These strategies are vital for improving treatment outcomes and long-term health for breast cancer patients.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Cancer Prevention
Some...
Imaging Studies for Cardiovascular System V: CT
Cardiovascular Drugs: Classification based on Therapeutic Indications

